By Memorial Sloan Kettering | Thursday, June 7, 2012
Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan Kettering and the long-term relationships he maintains with his patients.
By Memorial Sloan Kettering | Tuesday, June 5, 2012
Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
By Memorial Sloan Kettering | Tuesday, May 29, 2012
Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan Kettering | Monday, May 14, 2012
Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.
By Memorial Sloan Kettering | Monday, May 7, 2012
Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.
By Memorial Sloan Kettering | Thursday, May 3, 2012
Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.
By Memorial Sloan Kettering | Friday, April 27, 2012
Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan Kettering.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, April 25, 2012
Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.
By Memorial Sloan Kettering | Monday, April 23, 2012
Patty grew up playing in the sun at the beach, so when she developed a growth under her eye she knew it could be skin cancer. Experts at Memorial Sloan Kettering Basking Ridge diagnosed her with basal cell carcinoma and performed a highly specialized surgery to remove the cancer.
In the News
By Media Staff | Friday, April 20, 2012
In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
By Memorial Sloan Kettering | Monday, April 16, 2012
James Eastham, Chief of Memorial Sloan Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.
By Memorial Sloan Kettering | Monday, April 9, 2012
A routine blood test led to a diagnosis of bone cancer for Bruce, an otherwise healthy 43-year-old writer. Surgeons at Memorial Sloan Kettering removed his cancer and saved his leg, giving him the chance to resume his career as “the writer who walks.”
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Friday, April 6, 2012
A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.